Gefitinib toxicity has been significantly correlated with survival in non-small cell lung cancer patients treated in EAP program in Czech Republic
| Authors | |
|---|---|
| Year of publication | 2007 |
| Type | Article in Proceedings |
| Conference | Journal of Thoracic Oncology |
| MU Faculty or unit | |
| Citation | |
| Field | Oncology and hematology |
| Keywords | Gefitinib; toxicity; non-small cell lung cancer;survival |
| Description | Toxicity of the anti-tumour drug, Gefitinib, has been followed up in a multi-center study of non-small cell lung cancer and correlated with patients' survival. The results in the Czech leg of the study have suggested a significant correlation. |
| Related projects: |